Pancreatic Cancer Research

ResearcherNational Hospital Organization Kyushu Cancer CenterActive in the last 2 years

Tomohiro Iguchi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-8621-8126; OpenAlex author ID A5058931620, A5077062127. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 3 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 8

  1. Adjuvant S-1 Plus Metformin after Pancreatic Cancer Resection: A Multicenter Randomized Phase II Trial Co-author DOI 10.21203/rs.3.rs-9445035/v1↗
  2. Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ags3.12686↗
  3. Prognostic Impact of the Preoperative Systemic Inflammation Score in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1177/00031348221086782↗
  4. Prognostic Impact of Lymphocyte-to-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Pancreatic Cancer. First author DOI 10.1177/00031348221117034↗
  5. A case of successful conversion surgery for locally advanced pancreatic cancer with synchronous triple cancer of the lung and esophagus: a case report. First author DOI 10.1186/s40792-022-01377-x↗
  6. Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: A multi-institutional retrospective study. Co-author DOI 10.1016/j.pan.2021.08.003↗
  7. Mitochondrial expression of the DNA repair enzyme OGG1 improves the prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2020.07.011↗
  8. Impact of Osteopenia on Oncologic Outcomes After Curative Resection for Pancreatic Cancer. Co-author DOI 10.21873/invivo.12198↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroshi Matsuura · 4 shared papers, 2020–2023 · strength 0.63
  2. Shinji Itoh · 4 shared papers, 2020–2023 · strength 0.57
  3. Keishi Sugimachi · 4 shared papers, 2020–2023 · strength 0.54
  4. Norifumi Iseda · 3 shared papers, 2022–2023 · strength 0.52
  5. Takeshi Sudo · 1 shared paper, 2026 · strength 0.23
  6. Yutaka Itoh · 1 shared paper, 2026 · strength 0.23
  7. Mototsugu Shimokawa · 1 shared paper, 2026 · strength 0.23
  8. Masayuki Furukawa · 1 shared paper, 2026 · strength 0.23
  9. Masato Narita · 1 shared paper, 2026 · strength 0.23
  10. Masaki Mori · 2 shared papers, 2020–2021 · strength 0.20
  11. Tomoharu Yoshizumi · 2 shared papers, 2020–2021 · strength 0.20
  12. Tomonari Shimagaki · 1 shared paper, 2023 · strength 0.18
  13. Yasushi Toh · 1 shared paper, 2023 · strength 0.18
  14. Masaru Morita · 1 shared paper, 2023 · strength 0.18
  15. Junya Mita · 1 shared paper, 2022 · strength 0.14
  16. Takashi Motomura · 1 shared paper, 2020 · strength 0.11
  17. Tohru Utsunomiya · 1 shared paper, 2021 · strength 0.11
  18. Toru Ikegami · 1 shared paper, 2020 · strength 0.09
  19. Shoichi Inokuchi · 1 shared paper, 2020 · strength 0.09
  20. Yoshinao Oda · 1 shared paper, 2020 · strength 0.09
  21. Kyohei Yugawa · 1 shared paper, 2020 · strength 0.09
  22. Shohei Yoshiya · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.